ZA896674B - Medicaments - Google Patents
MedicamentsInfo
- Publication number
- ZA896674B ZA896674B ZA896674A ZA896674A ZA896674B ZA 896674 B ZA896674 B ZA 896674B ZA 896674 A ZA896674 A ZA 896674A ZA 896674 A ZA896674 A ZA 896674A ZA 896674 B ZA896674 B ZA 896674B
- Authority
- ZA
- South Africa
- Prior art keywords
- medicaments
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888820653A GB8820653D0 (en) | 1988-09-01 | 1988-09-01 | Medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA896674B true ZA896674B (en) | 1990-06-27 |
Family
ID=10643005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA896674A ZA896674B (en) | 1988-09-01 | 1989-08-31 | Medicaments |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0357414A3 (de) |
| JP (1) | JPH02180822A (de) |
| KR (1) | KR900004341A (de) |
| AU (1) | AU627770B2 (de) |
| CA (1) | CA1330535C (de) |
| DK (1) | DK432889A (de) |
| GB (1) | GB8820653D0 (de) |
| IL (1) | IL91481A0 (de) |
| PH (2) | PH26985A (de) |
| ZA (1) | ZA896674B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5276050A (en) * | 1989-08-01 | 1994-01-04 | Glaxo Group Limited | Medicaments |
| GB0305553D0 (en) * | 2003-03-11 | 2003-04-16 | Glaxo Group Ltd | Compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR871809B (en) * | 1986-11-28 | 1988-03-07 | Glaxo Group Ltd | Process for the preparation of tricyclic ketones |
| GB8630071D0 (en) * | 1986-12-17 | 1987-01-28 | Glaxo Group Ltd | Medicaments |
| US4973594A (en) * | 1986-12-17 | 1990-11-27 | Glaxo Group Limited | Medicaments |
| PH25493A (en) * | 1987-09-03 | 1991-07-24 | Glaxo Group Ltd | 2,3,4,5-tetrahydro-2-£(imidazol-(or-5)-yl)methyl-ih-pyrido£4,3-b|indol-1-ones , derivatives having 5-ht antagonist activity 3 |
-
1988
- 1988-09-01 GB GB888820653A patent/GB8820653D0/en active Pending
-
1989
- 1989-08-31 KR KR1019890012467A patent/KR900004341A/ko not_active Application Discontinuation
- 1989-08-31 ZA ZA896674A patent/ZA896674B/xx unknown
- 1989-08-31 IL IL91481A patent/IL91481A0/xx unknown
- 1989-08-31 CA CA000609995A patent/CA1330535C/en not_active Expired - Fee Related
- 1989-08-31 DK DK432889A patent/DK432889A/da unknown
- 1989-08-31 EP EP89308804A patent/EP0357414A3/de not_active Withdrawn
- 1989-08-31 PH PH39186A patent/PH26985A/en unknown
- 1989-08-31 PH PH39185A patent/PH26728A/en unknown
- 1989-08-31 AU AU40968/89A patent/AU627770B2/en not_active Ceased
- 1989-08-31 JP JP1226379A patent/JPH02180822A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DK432889A (da) | 1990-03-02 |
| IL91481A0 (en) | 1990-04-29 |
| DK432889D0 (da) | 1989-08-31 |
| EP0357414A3 (de) | 1990-06-13 |
| JPH02180822A (ja) | 1990-07-13 |
| KR900004341A (ko) | 1990-04-12 |
| CA1330535C (en) | 1994-07-05 |
| EP0357414A2 (de) | 1990-03-07 |
| PH26985A (en) | 1992-12-28 |
| PH26728A (en) | 1992-09-28 |
| AU4096889A (en) | 1990-03-08 |
| GB8820653D0 (en) | 1988-10-05 |
| AU627770B2 (en) | 1992-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP8900136A0 (en) | Medicaments | |
| GB8905400D0 (en) | Medicaments | |
| GB8915499D0 (en) | Medicaments | |
| GB8805269D0 (en) | Medicaments | |
| ZA891640B (en) | Medicaments | |
| GB8814726D0 (en) | Medicaments | |
| GB8820651D0 (en) | Medicaments | |
| GB8808599D0 (en) | Medicaments | |
| GB8820650D0 (en) | Medicaments | |
| ZA896674B (en) | Medicaments | |
| GB8814725D0 (en) | Medicaments | |
| GB8911166D0 (en) | Medicaments | |
| GB8828032D0 (en) | Medicaments | |
| GB8819708D0 (en) | Medicaments | |
| GB8804110D0 (en) | Medicaments | |
| GB8814728D0 (en) | Medicaments | |
| GB8819479D0 (en) | Medicaments | |
| GB8819480D0 (en) | Medicaments | |
| GB8822071D0 (en) | Medicaments | |
| GB8814727D0 (en) | Medicaments | |
| GB8808042D0 (en) | Medicaments | |
| GB8819707D0 (en) | Medicaments | |
| GB8826288D0 (en) | Medicaments | |
| GB8825392D0 (en) | Medicaments | |
| GB8814054D0 (en) | Medicaments |